Measurement of ergotamine in human plasma by triple sector quadrupole mass spectrometry with negative ion chemical ionization

This publication has 9 references indexed in Scilit:

• Determination of dihydroergocristine and dihydroergotamine in plasma by high-performance liquid chromatography with fluorescence detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1983
• Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers.
  British Journal of Clinical Pharmacology, 1983
• On the treatment of migraine. Pharmacokinetic-pharmacodynamic relationships for a programmed release formulation of dihydroergotamine administered orally in the human
  Cephalalgia, 1983
• Bioavailability of dihydroergotamine in man.
  British Journal of Clinical Pharmacology, 1982
• Low oral bioavailability of dihydroergotamine and first-pass extraction in patients with Orthostatic hypotension
  Clinical Pharmacology & Therapeutics, 1981
• Determination of ergot alkaloids in plasma by high-performance liquid chromatography and fluorescence detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1981
• Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension.
  BMJ, 1980
• Quantitative determination of ergot alkaloids in biological fluids by radioimmunoassay.
  British Journal of Clinical Pharmacology, 1978
• Identification of Ergot-peptide alkaloids, based on gas—liquid chromatography of the peptide moiety
  Journal of Chromatography A, 1978